HealthEquity Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
HealthEquity wird ein jährliches Gewinn- und Umsatzwachstum von 32.1% bzw. 11.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 30.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.1% betragen.
Wichtige Informationen
32.1%
Wachstumsrate der Gewinne
30.3%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 20.9% |
| Wachstumsrate der Einnahmen | 11.4% |
| Zukünftige Eigenkapitalrendite | 12.1% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 18 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 20
HealthEquity: High Marks For Recent Profit Growth
Nov 20We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt
Oct 31Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult
Aug 30HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy
Aug 27Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Jul 13We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation
Jun 21Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jun 07HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore
Jun 04HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind
May 29Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects
Dec 28Is HealthEquity (NASDAQ:HQY) A Risky Investment?
Nov 17HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price
Oct 26Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Jul 27HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 07Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Apr 18Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Mar 14Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Dec 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Dec 02Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 11These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Sep 08HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jul 27Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Jul 06These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
May 24Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 1/31/2027 | 1,467 | 228 | 459 | 488 | 8 |
| 1/31/2026 | 1,315 | 158 | 405 | 423 | 13 |
| 1/31/2025 | 1,183 | 110 | 308 | 320 | 13 |
| 7/31/2024 | 1,099 | 106 | -198 | 308 | N/A |
| 4/30/2024 | 1,043 | 80 | -30 | 277 | N/A |
| 1/31/2024 | 1,000 | 56 | 197 | 243 | N/A |
| 10/31/2023 | 971 | 29 | 176 | 221 | N/A |
| 7/31/2023 | 938 | 13 | 169 | 212 | N/A |
| 4/30/2023 | 901 | -8 | 121 | 175 | N/A |
| 1/31/2023 | 862 | -26 | 32 | 151 | N/A |
| 10/31/2022 | 831 | -59 | 21 | 146 | N/A |
| 7/31/2022 | 795 | -62 | -71 | 120 | N/A |
| 4/30/2022 | 778 | -55 | -76 | 117 | N/A |
| 1/31/2022 | 757 | -44 | 4 | 141 | N/A |
| 10/31/2021 | 741 | -6 | 10 | 151 | N/A |
| 7/31/2021 | 741 | 1 | 99 | 181 | N/A |
| 4/30/2021 | 728 | 4 | 108 | 198 | N/A |
| 1/31/2021 | 734 | 9 | 85 | 182 | N/A |
| 10/31/2020 | 747 | 3 | 64 | 152 | N/A |
| 7/31/2020 | 724 | -20 | 34 | 117 | N/A |
| 4/30/2020 | 635 | 0 | 35 | 95 | N/A |
| 1/31/2020 | 532 | 40 | 63 | 105 | N/A |
| 10/31/2019 | 407 | 53 | 72 | 107 | N/A |
| 7/31/2019 | 320 | 90 | 96 | 118 | N/A |
| 4/30/2019 | 304 | 93 | 96 | 116 | N/A |
| 1/31/2019 | 287 | 74 | 98 | 113 | N/A |
| 10/31/2018 | 272 | 67 | 82 | 101 | N/A |
| 7/31/2018 | 258 | 61 | 67 | 95 | N/A |
| 4/30/2018 | 244 | 56 | N/A | 89 | N/A |
| 1/31/2018 | 230 | 47 | N/A | 82 | N/A |
| 10/31/2017 | 216 | 46 | N/A | 76 | N/A |
| 7/31/2017 | 202 | 41 | N/A | 70 | N/A |
| 4/30/2017 | 190 | 32 | N/A | 59 | N/A |
| 1/31/2017 | 178 | 26 | N/A | 46 | N/A |
| 10/31/2016 | 167 | 25 | N/A | 39 | N/A |
| 7/31/2016 | 155 | 24 | N/A | 35 | N/A |
| 4/30/2016 | 141 | 20 | N/A | 27 | N/A |
| 1/31/2016 | 127 | 17 | N/A | 27 | N/A |
| 10/31/2015 | 116 | 15 | N/A | 23 | N/A |
| 7/31/2015 | 107 | 14 | N/A | 17 | N/A |
| 4/30/2015 | 97 | 13 | N/A | 15 | N/A |
| 1/31/2015 | 88 | 12 | N/A | 15 | N/A |
| 10/31/2014 | 80 | 1 | N/A | 16 | N/A |
| 7/31/2014 | 74 | -1 | N/A | 16 | N/A |
| 4/30/2014 | 68 | -4 | N/A | 16 | N/A |
| 1/31/2014 | 62 | -7 | N/A | 18 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: HQYDas prognostizierte Gewinnwachstum (32.1% pro Jahr) liegt über der Sparquote (2.6%).
Ertrag vs. Markt: HQYDie Erträge des Unternehmens (32.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.4% pro Jahr).
Hohe Wachstumserträge: HQYEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: HQYDie Einnahmen des Unternehmens (11.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.9% pro Jahr).
Hohe Wachstumseinnahmen: HQYDie Einnahmen des Unternehmens (11.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: HQYDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.1%).